Talon Group Consulting
Services
Strategic Growth & Market Enablement
Talon Group Consulting partners with life sciences leaders to build commercial strategies that turn market complexity into competitive advantage. We help clients identify and size the right opportunities, design technology-enabled go-to-market models, and build the business cases that unlock investment. Our work spans market prioritization, digital health strategy, portfolio positioning, and partnership design, grounded in rigorous analytics, real-world evidence, and deep domain expertise across therapeutics, geographies, and care settings.
Industry Pain Points We Turn Into Opportunities
-
Difficulty identifying which markets, indications, or patient segments represent the highest-value investment opportunities.
-
Lack of clarity on how digital health, AI, and real-world evidence reshape commercial models and competitive positioning.
-
Disconnect between R&D pipeline potential and commercial readiness across functions and geographies.
-
No structured framework for evaluating build vs. buy, partnership selection, or portfolio sequencing decisions.
-
Business cases for new indications, geographies, or digital offerings that lack the quantitative rigor to survive internal scrutiny.
-
Fragmented data assets and analytics capabilities that limit the ability to generate actionable market intelligence at scale.
A few of the ways in which we
support our clients:
Market Opportunity Reports
Granular market sizing, segmentation, and competitive landscape analyses across indications and geographies, built to withstand internal investment scrutiny.
Digital Product Launch & Innovation Roadmaps
Phased roadmaps integrating digital health, AI, and partnership strategies with specific milestones, investment requirements, and go-to-market sequencing.
Market Prioritization Models
Evidence-based prioritization frameworks that rank opportunities by revenue potential, strategic fit, and execution feasibility to sequence investments.
Strategic Recommendations
Prioritized, financially quantified recommendations on portfolio investment, partnership structure, and technology adoption, designed to win internal resource allocation.
Actionable Risk Assessments
Identification of potential risks and mitigation strategies across market, regulatory, and operational dimensions to ensure successful execution and protect investment returns.
Client Successes
Talon Group Consulting partnered with a global F100 life sciences company to design the commercial and digital health strategy for their neuroscience franchise. Delivered as a high-intensity, 3-month sprint across six parallel workstreams, the engagement spanned market sizing and opportunity analysis across multiple geographies, quantified business cases for new indications and market expansions, a digital health landscape assessment with prioritized partnership recommendations, and future-state patient journey design integrating drug and digital offerings. The work identified a multi-dimensional revenue opportunity exceeding $700M annually at peak, spanning five strategic levers across indications, geographies, and digitally-enabled adherence. Our recommendations gave enterprise leadership the evidence-grounded prioritization framework needed to sequence investments, structure partnerships, and position their franchise as a first-mover in integrated drug-digital commercial models.
Organizations we have worked with
